{"drugResultsOutput": {"Filters": {"@total": "14", "Filter": [{"@total": "100", "@label": "Technologies", "@name": "technologies", "FilterOption": [{"@id": "761", "@count": "1143", "@label": "Biological therapeutic"}, {"@id": "762", "@count": "783", "@label": "Small molecule therapeutic"}, {"@id": "766", "@count": "461", "@label": "Parenteral formulation unspecified"}, {"@id": "585", "@count": "258", "@label": "Oral formulation"}, {"@id": "648", "@count": "182", "@label": "Intravenous formulation"}, {"@id": "85", "@count": "178", "@label": "Protein recombinant"}, {"@id": "651", "@count": "165", "@label": "Intramuscular formulation"}, {"@id": "1668", "@count": "107", "@label": "Nanoparticle formulation"}, {"@id": "80", "@count": "101", "@label": "Peptide"}, {"@id": "647", "@count": "101", "@label": "Subcutaneous formulation"}, {"@id": "595", "@count": "95", "@label": "Tablet formulation"}, {"@id": "62", "@count": "85", "@label": "Virus recombinant"}, {"@id": "596", "@count": "84", "@label": "Injectable formulation"}, {"@id": "740", "@count": "81", "@label": "Infusion"}, {"@id": "605", "@count": "79", "@label": "Nasal systemic formulation"}, {"@id": "1647", "@count": "64", "@label": "Natural product"}, {"@id": "586", "@count": "52", "@label": "Capsule formulation"}, {"@id": "67", "@count": "52", "@label": "Antigen"}, {"@id": "599", "@count": "51", "@label": "Nanoparticle formulation injectable"}, {"@id": "616", "@count": "48", "@label": "Inhalant formulation"}, {"@id": "84", "@count": "46", "@label": "Protein fusion"}, {"@id": "603", "@count": "46", "@label": "Systemic formulation unspecified"}, {"@id": "66", "@count": "44", "@label": "Antibiotic"}, {"@id": "589", "@count": "43", "@label": "Sustained release formulation"}, {"@id": "142", "@count": "43", "@label": "Liposome formulation"}, {"@id": "168", "@count": "40", "@label": "Monoclonal antibody human"}, {"@id": "175", "@count": "39", "@label": "Drug combination"}, {"@id": "558", "@count": "39", "@label": "Transdermal formulation"}, {"@id": "103", "@count": "37", "@label": "Oligonucleotide"}, {"@id": "611", "@count": "28", "@label": "Dermatological formulation"}, {"@id": "851", "@count": "24", "@label": "Intradermal formulation"}, {"@id": "74", "@count": "24", "@label": "Glycoprotein"}, {"@id": "569", "@count": "24", "@label": "Oligonucleotide antisense"}, {"@id": "559", "@count": "24", "@label": "Oral controlled release formulation"}, {"@id": "777", "@count": "23", "@label": "Nasal formulation"}, {"@id": "751", "@count": "23", "@label": "Film coating"}, {"@id": "617", "@count": "23", "@label": "Aerosol formulation inhalant"}, {"@id": "962", "@count": "22", "@label": "Biosimilar product"}, {"@id": "207", "@count": "22", "@label": "Protein conjugated"}, {"@id": "598", "@count": "22", "@label": "Liposome formulation injectable"}, {"@id": "619", "@count": "21", "@label": "Nasal formulation local"}, {"@id": "215", "@count": "21", "@label": "Antigen presentation system"}, {"@id": "169", "@count": "21", "@label": "Monoclonal antibody humanized"}, {"@id": "166", "@count": "20", "@label": "Chimeric monoclonal antibody"}, {"@id": "961", "@count": "20", "@label": "Follow on biological product"}, {"@id": "746", "@count": "20", "@label": "Solution"}, {"@id": "593", "@count": "19", "@label": "Oral liquid formulation"}, {"@id": "1652", "@count": "19", "@label": "Prodrug"}, {"@id": "1669", "@count": "19", "@label": "Emulsion formulation"}, {"@id": "573", "@count": "19", "@label": "Immunoglobulin-G"}, {"@id": "51", "@count": "18", "@label": "Monoclonal antibody"}, {"@id": "600", "@count": "18", "@label": "Patch formulation"}, {"@id": "641", "@count": "18", "@label": "Controlled release formulation"}, {"@id": "127", "@count": "16", "@label": "Cell culture"}, {"@id": "349", "@count": "16", "@label": "Lipid"}, {"@id": "745", "@count": "16", "@label": "Suspension"}, {"@id": "594", "@count": "15", "@label": "Oral suspension formulation"}, {"@id": "660", "@count": "15", "@label": "Oral sustained release formulation"}, {"@id": "180", "@count": "14", "@label": "Antibody fragment"}, {"@id": "606", "@count": "13", "@label": "Transmucosal formulation"}, {"@id": "1646", "@count": "13", "@label": "Injectable controlled release formulation"}, {"@id": "618", "@count": "13", "@label": "Powder formulation inhalant"}, {"@id": "348", "@count": "13", "@label": "PEGylated formulation"}, {"@id": "612", "@count": "13", "@label": "Emulsion dermatological"}, {"@id": "102", "@count": "12", "@label": "Nucleotide and derivatives"}, {"@id": "753", "@count": "12", "@label": "Microparticle formulation"}, {"@id": "347", "@count": "11", "@label": "Intratumoral formulation"}, {"@id": "112", "@count": "11", "@label": "DNA technology"}, {"@id": "680", "@count": "10", "@label": "Buccal formulation systemic"}, {"@id": "902", "@count": "10", "@label": "Orally disintegrating tablet"}, {"@id": "750", "@count": "10", "@label": "Freeze drying"}, {"@id": "1653", "@count": "10", "@label": "Tumor antigen"}, {"@id": "743", "@count": "10", "@label": "Granule"}, {"@id": "1667", "@count": "10", "@label": "Nanoparticle formulation dermatological"}, {"@id": "591", "@count": "9", "@label": "Nanoparticle formulation oral"}, {"@id": "159", "@count": "8", "@label": "Oligosaccharide"}, {"@id": "83", "@count": "8", "@label": "Protein chimeric"}, {"@id": "590", "@count": "8", "@label": "Enteric coated formulation"}, {"@id": "570", "@count": "8", "@label": "Cell therapy"}, {"@id": "897", "@count": "7", "@label": "Formulation aerosol"}, {"@id": "1", "@count": "7", "@label": "Antibody"}, {"@id": "560", "@count": "7", "@label": "Drug implant"}, {"@id": "232", "@count": "7", "@label": "Virus novel"}, {"@id": "901", "@count": "7", "@label": "Recombinant enzyme"}, {"@id": "620", "@count": "7", "@label": "Ophthalmic formulation"}, {"@id": "92", "@count": "7", "@label": "Viral coat protein"}, {"@id": "667", "@count": "5", "@label": "Peptidomimetic"}, {"@id": "287", "@count": "5", "@label": "Transdermal high velocity particle formulation"}, {"@id": "597", "@count": "5", "@label": "Injectable emulsion"}, {"@id": "764", "@count": "5", "@label": "Local formulation unspecified"}, {"@id": "623", "@count": "5", "@label": "Vaginal formulation"}, {"@id": "171", "@count": "5", "@label": "Monoclonal antibody conjugated"}, {"@id": "1655", "@count": "5", "@label": "Tumor antigen therapeutic"}, {"@id": "117", "@count": "5", "@label": "RNA technology"}, {"@id": "630", "@count": "5", "@label": "Stereochemistry"}, {"@id": "1663", "@count": "4", "@label": "Gel formulation"}, {"@id": "661", "@count": "4", "@label": "Oral quick release formulation"}, {"@id": "90", "@count": "4", "@label": "Steroid"}, {"@id": "724", "@count": "4", "@label": "Radiolabeling"}, {"@id": "731", "@count": "4", "@label": "Imaging"}]}, {"@total": "100", "@label": "Secondary Actions", "@name": "actionsSecondary", "FilterOption": [{"@id": "12378", "@count": "558", "@label": "Prophylactic vaccine"}, {"@id": "991", "@count": "496", "@label": "Antiviral"}, {"@id": "59620", "@count": "283", "@label": "Unspecified drug target"}, {"@id": "1545", "@count": "263", "@label": "Anticancer"}, {"@id": "12367", "@count": "144", "@label": "Inactivated viral vaccine"}, {"@id": "12372", "@count": "135", "@label": "Protein subunit vaccine"}, {"@id": "12379", "@count": "129", "@label": "Therapeutic vaccine"}, {"@id": "2953", "@count": "111", "@label": "Anti-inflammatory"}, {"@id": "524", "@count": "91", "@label": "Adjuvant"}, {"@id": "393", "@count": "80", "@label": "Immunostimulant"}, {"@id": "1594", "@count": "79", "@label": "Antibacterial"}, {"@id": "1879", "@count": "74", "@label": "DNA vaccine"}, {"@id": "12370", "@count": "68", "@label": "Recombinant viral vector vaccine"}, {"@id": "2576", "@count": "65", "@label": "Microtubule stabilizer"}, {"@id": "12364", "@count": "63", "@label": "Live attenuated viral vaccine"}, {"@id": "12380", "@count": "60", "@label": "Unspecified vaccine"}, {"@id": "1532", "@count": "55", "@label": "Viral replication inhibitor"}, {"@id": "2946", "@count": "48", "@label": "Analgesic"}, {"@id": "767", "@count": "42", "@label": "Cell cycle inhibitor"}, {"@id": "55685", "@count": "37", "@label": "Anticancer monoclonal antibody"}, {"@id": "12371", "@count": "35", "@label": "Subunit vaccine"}, {"@id": "2575", "@count": "34", "@label": "Microtubule inhibitor"}, {"@id": "1596", "@count": "34", "@label": "Immunomodulator"}, {"@id": "610", "@count": "31", "@label": "Hematopoietic stimulant"}, {"@id": "399", "@count": "29", "@label": "Hypoglycemic agent"}, {"@id": "1615", "@count": "28", "@label": "Neuroprotectant"}, {"@id": "499", "@count": "27", "@label": "Tubulin binding agent"}, {"@id": "750", "@count": "24", "@label": "DNA intercalator"}, {"@id": "7294", "@count": "23", "@label": "Antisense oligonucleotide inhibitor"}, {"@id": "386", "@count": "21", "@label": "Vaccine"}, {"@id": "15184", "@count": "20", "@label": "Systemic antipsoriatic product"}, {"@id": "62255", "@count": "20", "@label": "Anticancer protein kinase inhibitor"}, {"@id": "1589", "@count": "19", "@label": "Apoptosis stimulator"}, {"@id": "2660", "@count": "19", "@label": "Vasoprotectant"}, {"@id": "284", "@count": "18", "@label": "Nootropic agent"}, {"@id": "50", "@count": "18", "@label": "Anticancer alkylating agent"}, {"@id": "396", "@count": "18", "@label": "Immunosuppressant"}, {"@id": "1470", "@count": "17", "@label": "Respiratory system agent"}, {"@id": "2657", "@count": "17", "@label": "Antihypertensive"}, {"@id": "1748", "@count": "16", "@label": "Fungicide"}, {"@id": "12377", "@count": "16", "@label": "RNA vaccine"}, {"@id": "71", "@count": "16", "@label": "Antihypercholesterolemic agent"}, {"@id": "1720", "@count": "15", "@label": "Virus uptake inhibitor"}, {"@id": "104", "@count": "15", "@label": "Bacterial cell wall synthesis inhibitor"}, {"@id": "26035", "@count": "15", "@label": "siRNA agent"}, {"@id": "12375", "@count": "15", "@label": "Toxoid vaccine"}, {"@id": "15187", "@count": "14", "@label": "Systemic dermatological antibacterial product"}, {"@id": "61", "@count": "13", "@label": "Angiogenesis inhibitor"}, {"@id": "62253", "@count": "12", "@label": "Anticancer hormone"}, {"@id": "2667", "@count": "12", "@label": "Antiarteriosclerotic"}, {"@id": "72", "@count": "11", "@label": "Antihyperlipidemic agent"}, {"@id": "2659", "@count": "10", "@label": "Cardioprotectant"}, {"@id": "2955", "@count": "10", "@label": "Non-steroidal anti-inflammatory"}, {"@id": "32414", "@count": "10", "@label": "Influenza virus replication inhibitor"}, {"@id": "32415", "@count": "10", "@label": "Influenza A virus replication inhibitor"}, {"@id": "38200", "@count": "8", "@label": "Acid pump inhibitor antiulcerant product"}, {"@id": "1593", "@count": "8", "@label": "Antimicrobial"}, {"@id": "439", "@count": "8", "@label": "RNA synthesis inhibitor"}, {"@id": "1919", "@count": "8", "@label": "Insulin sensitizer"}, {"@id": "463", "@count": "7", "@label": "Ribosome binding agent"}, {"@id": "15319", "@count": "7", "@label": "Hepatitis C virus replication inhibitor"}, {"@id": "3984", "@count": "7", "@label": "Bacterial nucleic acid synthesis inhibitor"}, {"@id": "12369", "@count": "7", "@label": "Recombinant bacterial vector vaccine"}, {"@id": "7293", "@count": "7", "@label": "Synergist"}, {"@id": "182", "@count": "7", "@label": "Gastric secretion inhibitor"}, {"@id": "7761", "@count": "7", "@label": "T-lymphocyte stimulator"}, {"@id": "1332", "@count": "7", "@label": "Gastrointestinal system agent"}, {"@id": "12373", "@count": "7", "@label": "Polysaccharide subunit vaccine"}, {"@id": "140", "@count": "6", "@label": "DNA synthesis inhibitor"}, {"@id": "312", "@count": "6", "@label": "Platelet aggregation inhibitor"}, {"@id": "7292", "@count": "6", "@label": "Vulnerary agent"}, {"@id": "2638", "@count": "6", "@label": "Antiparasitic"}, {"@id": "2947", "@count": "6", "@label": "Antiparkinsonian"}, {"@id": "747", "@count": "5", "@label": "HIV replication inhibitor"}, {"@id": "721", "@count": "5", "@label": "TNF binding agent"}, {"@id": "2941", "@count": "5", "@label": "Antidepressant"}, {"@id": "664", "@count": "5", "@label": "Fibrosuppressant"}, {"@id": "1538", "@count": "5", "@label": "Bacterial protein synthesis inhibitor"}, {"@id": "1669", "@count": "5", "@label": "Local anesthetic"}, {"@id": "1540", "@count": "5", "@label": "Macrolide antibiotic"}, {"@id": "89", "@count": "5", "@label": "Bone resorption inhibitor"}, {"@id": "659", "@count": "5", "@label": "Coagulation inhibitor"}, {"@id": "15128", "@count": "5", "@label": "Ophthalmological agent"}, {"@id": "1832", "@count": "5", "@label": "Nucleoside reverse transcriptase inhibitor"}, {"@id": "1537", "@count": "5", "@label": "Cephalosporin"}, {"@id": "3980", "@count": "4", "@label": "HIV fusion inhibitor"}, {"@id": "1465", "@count": "4", "@label": "Radioprotectant"}, {"@id": "1552", "@count": "4", "@label": "Radioimmunotherapeutic"}, {"@id": "137", "@count": "4", "@label": "Diuretic agent"}, {"@id": "712", "@count": "4", "@label": "Smooth muscle relaxant"}, {"@id": "74", "@count": "4", "@label": "Antioxidant agent"}, {"@id": "12363", "@count": "4", "@label": "Live attenuated bacterial vaccine"}, {"@id": "12374", "@count": "4", "@label": "Lipid subunit vaccine"}, {"@id": "1467", "@count": "4", "@label": "Renal system agent"}, {"@id": "1590", "@count": "4", "@label": "Apoptosis inhibitor"}, {"@id": "15180", "@count": "4", "@label": "Topical antipruritic product"}, {"@id": "3184", "@count": "3", "@label": "Prostaglandin metabolism modulator"}, {"@id": "339", "@count": "3", "@label": "Protein synthesis inhibitor"}, {"@id": "15183", "@count": "3", "@label": "Topical antipsoriatic product"}, {"@id": "15186", "@count": "3", "@label": "Topical dermatological antibacterial product"}]}, {"@total": "100", "@label": "Secondary Indications", "@name": "indicationsSecondary", "FilterOption": [{"@id": "191", "@count": "297", "@label": "Influenza virus infection"}, {"@id": "651", "@count": "109", "@label": "Cancer"}, {"@id": "344", "@count": "41", "@label": "Viral infection"}, {"@id": "158", "@count": "38", "@label": "HIV infection"}, {"@id": "725", "@count": "25", "@label": "Solid tumor"}, {"@id": "153", "@count": "22", "@label": "Hepatitis C virus infection"}, {"@id": "49", "@count": "21", "@label": "Breast tumor"}, {"@id": "36", "@count": "20", "@label": "Autoimmune disease"}, {"@id": "152", "@count": "19", "@label": "Hepatitis B virus infection"}, {"@id": "291", "@count": "19", "@label": "Rheumatoid arthritis"}, {"@id": "276", "@count": "18", "@label": "Prostate tumor"}, {"@id": "384", "@count": "18", "@label": "Vaccination"}, {"@id": "281", "@count": "17", "@label": "Psoriasis"}, {"@id": "799", "@count": "16", "@label": "Ovary tumor"}, {"@id": "249", "@count": "16", "@label": "Pancreas tumor"}, {"@id": "31", "@count": "16", "@label": "Asthma"}, {"@id": "188", "@count": "16", "@label": "Inflammatory disease"}, {"@id": "14", "@count": "15", "@label": "Alzheimers disease"}, {"@id": "755", "@count": "15", "@label": "Lung tumor"}, {"@id": "157", "@count": "14", "@label": "Herpes simplex virus infection"}, {"@id": "213", "@count": "13", "@label": "Multiple sclerosis"}, {"@id": "205", "@count": "13", "@label": "Melanoma"}, {"@id": "40", "@count": "12", "@label": "Bacterial infection"}, {"@id": "396", "@count": "12", "@label": "Papillomavirus infection"}, {"@id": "989", "@count": "12", "@label": "Colorectal tumor"}, {"@id": "1783", "@count": "11", "@label": "SARS coronavirus infection"}, {"@id": "20", "@count": "11", "@label": "Pain"}, {"@id": "84", "@count": "11", "@label": "Crohns disease"}, {"@id": "287", "@count": "11", "@label": "Respiratory syncytial virus infection"}, {"@id": "1262", "@count": "11", "@label": "Non-small-cell lung cancer"}, {"@id": "72", "@count": "11", "@label": "Clostridium tetani infection"}, {"@id": "124", "@count": "10", "@label": "Fungal infection"}, {"@id": "1005", "@count": "10", "@label": "Unidentified indication"}, {"@id": "427", "@count": "9", "@label": "Uterine cervix tumor"}, {"@id": "746", "@count": "9", "@label": "Infectious disease"}, {"@id": "1267", "@count": "9", "@label": "MRSA infection"}, {"@id": "81", "@count": "8", "@label": "Corynebacterium diphtheriae infection"}, {"@id": "145", "@count": "8", "@label": "Haemophilus influenzae infection"}, {"@id": "767", "@count": "8", "@label": "Colon tumor"}, {"@id": "337", "@count": "8", "@label": "Ulcerative colitis"}, {"@id": "515", "@count": "8", "@label": "Transplant rejection"}, {"@id": "127", "@count": "7", "@label": "Stomach tumor"}, {"@id": "623", "@count": "7", "@label": "Head and neck tumor"}, {"@id": "54", "@count": "7", "@label": "Carcinoma"}, {"@id": "89", "@count": "7", "@label": "Cytomegalovirus infection"}, {"@id": "202", "@count": "7", "@label": "Liver tumor"}, {"@id": "47", "@count": "7", "@label": "Bordetella pertussis infection"}, {"@id": "159", "@count": "6", "@label": "HIV-1 infection"}, {"@id": "1766", "@count": "6", "@label": "Renal cell carcinoma"}, {"@id": "836", "@count": "6", "@label": "Insulin dependent diabetes"}, {"@id": "999", "@count": "6", "@label": "Renal tumor"}, {"@id": "837", "@count": "6", "@label": "Non-insulin dependent diabetes"}, {"@id": "1484", "@count": "6", "@label": "Bacterial respiratory tract infection"}, {"@id": "760", "@count": "6", "@label": "Brain tumor"}, {"@id": "319", "@count": "6", "@label": "Non-Hodgkin lymphoma"}, {"@id": "318", "@count": "6", "@label": "Systemic lupus erythematosus"}, {"@id": "12", "@count": "5", "@label": "Allergy"}, {"@id": "199", "@count": "5", "@label": "Leukemia"}, {"@id": "316", "@count": "5", "@label": "B-cell lymphoma"}, {"@id": "3246", "@count": "5", "@label": "Hormone refractory prostate cancer"}, {"@id": "33", "@count": "5", "@label": "Atherosclerosis"}, {"@id": "1828", "@count": "5", "@label": "Multiple myeloma"}, {"@id": "185", "@count": "5", "@label": "Immune disorder"}, {"@id": "1049", "@count": "5", "@label": "Ebola virus infection"}, {"@id": "1281", "@count": "5", "@label": "West Nile virus infection"}, {"@id": "114", "@count": "5", "@label": "Sepsis"}, {"@id": "88", "@count": "4", "@label": "Cystic fibrosis"}, {"@id": "97", "@count": "4", "@label": "Diabetes mellitus"}, {"@id": "221", "@count": "4", "@label": "Mycobacterium tuberculosis infection"}, {"@id": "646", "@count": "4", "@label": "Lung inflammation"}, {"@id": "189", "@count": "4", "@label": "Inflammatory bowel disease"}, {"@id": "174", "@count": "4", "@label": "Hypercholesterolemia"}, {"@id": "1767", "@count": "4", "@label": "Hepatocellular carcinoma"}, {"@id": "268", "@count": "4", "@label": "Plasmodium infection"}, {"@id": "360", "@count": "4", "@label": "Pneumonia"}, {"@id": "194", "@count": "4", "@label": "Sarcoma"}, {"@id": "1185", "@count": "4", "@label": "Chronic obstructive pulmonary disease"}, {"@id": "1485", "@count": "4", "@label": "Viral respiratory tract infection"}, {"@id": "187", "@count": "4", "@label": "Urinary incontinence"}, {"@id": "65", "@count": "4", "@label": "Stroke"}, {"@id": "286", "@count": "4", "@label": "Renal disease"}, {"@id": "1261", "@count": "4", "@label": "Small-cell lung cancer"}, {"@id": "509", "@count": "4", "@label": "Respiratory tract infection"}, {"@id": "1226", "@count": "4", "@label": "Age related macular degeneration"}, {"@id": "17", "@count": "4", "@label": "Anemia"}, {"@id": "1076", "@count": "4", "@label": "Thrombosis"}, {"@id": "1011", "@count": "3", "@label": "Esophagus tumor"}, {"@id": "655", "@count": "3", "@label": "Metabolic disorder"}, {"@id": "1069", "@count": "3", "@label": "Metastasis"}, {"@id": "165", "@count": "3", "@label": "HSV-2 infection"}, {"@id": "1263", "@count": "3", "@label": "Mucositis"}, {"@id": "292", "@count": "3", "@label": "Rhinovirus infection"}, {"@id": "1764", "@count": "3", "@label": "Basal cell carcinoma"}, {"@id": "616", "@count": "3", "@label": "Graft versus host disease"}, {"@id": "485", "@count": "3", "@label": "Bacterial skin infection"}, {"@id": "122", "@count": "3", "@label": "Flavivirus infection"}, {"@id": "936", "@count": "3", "@label": "Kaposis sarcoma"}, {"@id": "1815", "@count": "3", "@label": "Bacterial pneumonia"}, {"@id": "1108", "@count": "3", "@label": "Glioma"}, {"@id": "39", "@count": "3", "@label": "Bacillus anthracis infection"}]}, {"@total": "100", "@label": "Primary Indications", "@name": "indicationsPrimary", "FilterOption": [{"@id": "191", "@count": "439", "@label": "Influenza virus infection"}, {"@id": "651", "@count": "83", "@label": "Cancer"}, {"@id": "344", "@count": "42", "@label": "Viral infection"}, {"@id": "3455", "@count": "39", "@label": "Influenza virus A infection"}, {"@id": "158", "@count": "34", "@label": "HIV infection"}, {"@id": "153", "@count": "32", "@label": "Hepatitis C virus infection"}, {"@id": "20", "@count": "31", "@label": "Pain"}, {"@id": "145", "@count": "30", "@label": "Haemophilus influenzae infection"}, {"@id": "49", "@count": "30", "@label": "Breast tumor"}, {"@id": "152", "@count": "28", "@label": "Hepatitis B virus infection"}, {"@id": "17", "@count": "26", "@label": "Anemia"}, {"@id": "40", "@count": "26", "@label": "Bacterial infection"}, {"@id": "384", "@count": "24", "@label": "Vaccination"}, {"@id": "725", "@count": "22", "@label": "Solid tumor"}, {"@id": "1262", "@count": "21", "@label": "Non-small-cell lung cancer"}, {"@id": "313", "@count": "20", "@label": "Streptococcus pneumoniae infection"}, {"@id": "623", "@count": "20", "@label": "Head and neck tumor"}, {"@id": "799", "@count": "19", "@label": "Ovary tumor"}, {"@id": "291", "@count": "19", "@label": "Rheumatoid arthritis"}, {"@id": "287", "@count": "19", "@label": "Respiratory syncytial virus infection"}, {"@id": "31", "@count": "17", "@label": "Asthma"}, {"@id": "14", "@count": "17", "@label": "Alzheimers disease"}, {"@id": "989", "@count": "16", "@label": "Colorectal tumor"}, {"@id": "205", "@count": "15", "@label": "Melanoma"}, {"@id": "1815", "@count": "14", "@label": "Bacterial pneumonia"}, {"@id": "213", "@count": "14", "@label": "Multiple sclerosis"}, {"@id": "837", "@count": "14", "@label": "Non-insulin dependent diabetes"}, {"@id": "178", "@count": "13", "@label": "Hypertension"}, {"@id": "746", "@count": "13", "@label": "Infectious disease"}, {"@id": "319", "@count": "13", "@label": "Non-Hodgkin lymphoma"}, {"@id": "39", "@count": "12", "@label": "Bacillus anthracis infection"}, {"@id": "127", "@count": "12", "@label": "Stomach tumor"}, {"@id": "47", "@count": "12", "@label": "Bordetella pertussis infection"}, {"@id": "308", "@count": "11", "@label": "Staphylococcus aureus infection"}, {"@id": "394", "@count": "11", "@label": "Otitis media"}, {"@id": "485", "@count": "11", "@label": "Bacterial skin infection"}, {"@id": "249", "@count": "11", "@label": "Pancreas tumor"}, {"@id": "120", "@count": "11", "@label": "Escherichia coli infection"}, {"@id": "3657", "@count": "11", "@label": "Metastatic breast cancer"}, {"@id": "1243", "@count": "11", "@label": "Gastroesophageal reflux"}, {"@id": "188", "@count": "11", "@label": "Inflammatory disease"}, {"@id": "159", "@count": "10", "@label": "HIV-1 infection"}, {"@id": "398", "@count": "10", "@label": "Ankylosing spondylitis"}, {"@id": "1011", "@count": "10", "@label": "Esophagus tumor"}, {"@id": "84", "@count": "10", "@label": "Crohns disease"}, {"@id": "114", "@count": "10", "@label": "Sepsis"}, {"@id": "174", "@count": "10", "@label": "Hypercholesterolemia"}, {"@id": "72", "@count": "10", "@label": "Clostridium tetani infection"}, {"@id": "81", "@count": "10", "@label": "Corynebacterium diphtheriae infection"}, {"@id": "1455", "@count": "9", "@label": "Moraxella catarrhalis infection"}, {"@id": "221", "@count": "9", "@label": "Mycobacterium tuberculosis infection"}, {"@id": "280", "@count": "9", "@label": "Pseudomonas aeruginosa infection"}, {"@id": "276", "@count": "9", "@label": "Prostate tumor"}, {"@id": "1781", "@count": "9", "@label": "Psoriatic arthritis"}, {"@id": "396", "@count": "9", "@label": "Papillomavirus infection"}, {"@id": "1783", "@count": "9", "@label": "SARS coronavirus infection"}, {"@id": "1734", "@count": "9", "@label": "Chronic lymphocytic leukemia"}, {"@id": "88", "@count": "9", "@label": "Cystic fibrosis"}, {"@id": "2376", "@count": "8", "@label": "Overactive bladder"}, {"@id": "312", "@count": "8", "@label": "Streptococcus infection"}, {"@id": "1484", "@count": "8", "@label": "Bacterial respiratory tract infection"}, {"@id": "175", "@count": "8", "@label": "Hyperlipidemia"}, {"@id": "157", "@count": "8", "@label": "Herpes simplex virus infection"}, {"@id": "65", "@count": "8", "@label": "Stroke"}, {"@id": "89", "@count": "8", "@label": "Cytomegalovirus infection"}, {"@id": "3003", "@count": "8", "@label": "Juvenile rheumatoid arthritis"}, {"@id": "2380", "@count": "8", "@label": "Bladder cancer"}, {"@id": "1766", "@count": "7", "@label": "Renal cell carcinoma"}, {"@id": "281", "@count": "7", "@label": "Psoriasis"}, {"@id": "1108", "@count": "7", "@label": "Glioma"}, {"@id": "285", "@count": "7", "@label": "Rabies virus infection"}, {"@id": "2345", "@count": "7", "@label": "Tonsillitis"}, {"@id": "318", "@count": "7", "@label": "Systemic lupus erythematosus"}, {"@id": "3456", "@count": "7", "@label": "Influenza virus B infection"}, {"@id": "755", "@count": "7", "@label": "Lung tumor"}, {"@id": "403", "@count": "7", "@label": "Cystitis"}, {"@id": "3658", "@count": "7", "@label": "Metastatic colorectal cancer"}, {"@id": "1798", "@count": "7", "@label": "Bacterial urinary tract infection"}, {"@id": "1487", "@count": "7", "@label": "Acute bronchitis"}, {"@id": "309", "@count": "7", "@label": "Staphylococcus infection"}, {"@id": "337", "@count": "7", "@label": "Ulcerative colitis"}, {"@id": "33", "@count": "7", "@label": "Atherosclerosis"}, {"@id": "808", "@count": "7", "@label": "Duodenal ulcer"}, {"@id": "1767", "@count": "7", "@label": "Hepatocellular carcinoma"}, {"@id": "3246", "@count": "6", "@label": "Hormone refractory prostate cancer"}, {"@id": "151", "@count": "6", "@label": "Hepatitis A virus infection"}, {"@id": "836", "@count": "6", "@label": "Insulin dependent diabetes"}, {"@id": "638", "@count": "6", "@label": "Klebsiella infection"}, {"@id": "768", "@count": "6", "@label": "Behcets disease"}, {"@id": "810", "@count": "6", "@label": "Esophagitis"}, {"@id": "1267", "@count": "6", "@label": "MRSA infection"}, {"@id": "1828", "@count": "6", "@label": "Multiple myeloma"}, {"@id": "116", "@count": "6", "@label": "Enterobacter infection"}, {"@id": "36", "@count": "6", "@label": "Autoimmune disease"}, {"@id": "1061", "@count": "6", "@label": "Sinusitis"}, {"@id": "2458", "@count": "6", "@label": "Dengue virus infection"}, {"@id": "284", "@count": "6", "@label": "Pyelonephritis"}, {"@id": "1049", "@count": "5", "@label": "Ebola virus infection"}, {"@id": "767", "@count": "5", "@label": "Colon tumor"}, {"@id": "353", "@count": "5", "@label": "Cognitive disorder"}]}, {"@total": "100", "@label": "Primary Actions", "@name": "actionsPrimary", "FilterOption": [{"@id": "447", "@count": "37", "@label": "Exo-alpha sialidase inhibitor"}, {"@id": "52120", "@count": "36", "@label": "Hemagglutinin modulator"}, {"@id": "138", "@count": "33", "@label": "DNA polymerase inhibitor"}, {"@id": "142", "@count": "29", "@label": "Topoisomerase II inhibitor"}, {"@id": "12162", "@count": "27", "@label": "Erythropoietin ligand"}, {"@id": "205", "@count": "23", "@label": "HMG CoA reductase inhibitor"}, {"@id": "293", "@count": "15", "@label": "Opioid receptor mu agonist"}, {"@id": "740", "@count": "14", "@label": "Epidermal growth factor antagonist"}, {"@id": "208", "@count": "14", "@label": "H+ K+ ATPase inhibitor"}, {"@id": "483", "@count": "13", "@label": "Interferon alpha ligand"}, {"@id": "259", "@count": "13", "@label": "Muscarinic receptor antagonist"}, {"@id": "52122", "@count": "12", "@label": "Hemagglutinin inhibitor"}, {"@id": "498", "@count": "10", "@label": "Sodium channel inhibitor"}, {"@id": "19", "@count": "9", "@label": "Acetylcholinesterase inhibitor"}, {"@id": "2480", "@count": "9", "@label": "PPAR gamma agonist"}, {"@id": "347", "@count": "8", "@label": "RNA polymerase inhibitor"}, {"@id": "431", "@count": "8", "@label": "DNA gyrase inhibitor"}, {"@id": "7809", "@count": "8", "@label": "TLR-3 agonist"}, {"@id": "33689", "@count": "7", "@label": "Influenza matrix protein 2 inhibitor"}, {"@id": "12349", "@count": "7", "@label": "Hepatitis C virus NS3 protease inhibitor"}, {"@id": "214", "@count": "7", "@label": "Interferon alpha 2 ligand"}, {"@id": "2501", "@count": "7", "@label": "Erythropoietin receptor agonist"}, {"@id": "788", "@count": "6", "@label": "Angiotensin II AT-1 receptor antagonist"}, {"@id": "7812", "@count": "6", "@label": "TLR-4 agonist"}, {"@id": "9424", "@count": "5", "@label": "Unspecified ion channel inhibitor"}, {"@id": "2420", "@count": "5", "@label": "Beta amyloid modulator"}, {"@id": "9320", "@count": "5", "@label": "Topoisomerase IV inhibitor"}, {"@id": "52108", "@count": "5", "@label": "Respiratory syncytial virus protein F modulator"}, {"@id": "1310", "@count": "5", "@label": "Endonuclease inhibitor"}, {"@id": "372", "@count": "5", "@label": "Thymidylate synthase inhibitor"}, {"@id": "1483", "@count": "5", "@label": "Exo-alpha sialidase modulator"}, {"@id": "3755", "@count": "4", "@label": "Erbb2 tyrosine kinase receptor modulator"}, {"@id": "93", "@count": "4", "@label": "Calcium channel inhibitor"}, {"@id": "7800", "@count": "4", "@label": "TLR agonist"}, {"@id": "12481", "@count": "4", "@label": "Interleukin-2 ligand"}, {"@id": "481", "@count": "4", "@label": "Interferon beta ligand"}, {"@id": "12347", "@count": "4", "@label": "Hepatitis C virus NS3 protease modulator"}, {"@id": "629", "@count": "4", "@label": "Inosine monophosphate dehydrogenase inhibitor"}, {"@id": "9671", "@count": "4", "@label": "Unspecified protein kinase inhibitor"}, {"@id": "64", "@count": "4", "@label": "Angiotensin II receptor antagonist"}, {"@id": "23014", "@count": "4", "@label": "Insulin ligand"}, {"@id": "19334", "@count": "4", "@label": "HLA class II antigen modulator"}, {"@id": "400", "@count": "4", "@label": "Insulin receptor agonist"}, {"@id": "281", "@count": "4", "@label": "NMDA receptor antagonist"}, {"@id": "349", "@count": "3", "@label": "Serine protease inhibitor"}, {"@id": "13608", "@count": "3", "@label": "Survivin protein inhibitor"}, {"@id": "132", "@count": "3", "@label": "Cyclooxygenase inhibitor"}, {"@id": "1001", "@count": "3", "@label": "Cyclooxygenase 2 inhibitor"}, {"@id": "21480", "@count": "3", "@label": "CSF2 gene stimulator"}, {"@id": "377", "@count": "3", "@label": "TGF beta antagonist"}, {"@id": "212", "@count": "3", "@label": "Interferon agonist"}, {"@id": "8501", "@count": "3", "@label": "Interferon receptor modulator"}, {"@id": "3754", "@count": "3", "@label": "EGFR family tyrosine kinase receptor inhibitor"}, {"@id": "33687", "@count": "3", "@label": "Influenza matrix protein 2 modulator"}, {"@id": "33686", "@count": "3", "@label": "Influenza matrix protein 1 inhibitor"}, {"@id": "1016", "@count": "3", "@label": "HIV-1 reverse transcriptase inhibitor"}, {"@id": "11466", "@count": "3", "@label": "HIV gp41 protein modulator"}, {"@id": "2653", "@count": "3", "@label": "Nuclear factor kappa B inhibitor"}, {"@id": "341", "@count": "3", "@label": "Purine nucleoside phosphorylase inhibitor"}, {"@id": "3605", "@count": "3", "@label": "Epidermal growth factor receptor modulator"}, {"@id": "287", "@count": "3", "@label": "Opioid receptor agonist"}, {"@id": "12358", "@count": "3", "@label": "Hepatitis C virus NS5B polymerase inhibitor"}, {"@id": "4913", "@count": "3", "@label": "P2Y12 purinoceptor antagonist"}, {"@id": "7163", "@count": "3", "@label": "Glucosylceramidase stimulator"}, {"@id": "57003", "@count": "3", "@label": "Peptidoglycan recognition protein inhibitor"}, {"@id": "5083", "@count": "3", "@label": "B-lymphocyte antigen CD20 modulator"}, {"@id": "2651", "@count": "3", "@label": "Transcription factor inhibitor"}, {"@id": "9274", "@count": "3", "@label": "2,5-Oligoadenylate synthetase stimulator"}, {"@id": "5085", "@count": "3", "@label": "B-lymphocyte antigen CD20 inhibitor"}, {"@id": "381", "@count": "3", "@label": "TNF alpha ligand inhibitor"}, {"@id": "379", "@count": "3", "@label": "Trypsin inhibitor"}, {"@id": "8805", "@count": "3", "@label": "AMP activated protein kinase stimulator"}, {"@id": "7824", "@count": "3", "@label": "TLR-8 agonist"}, {"@id": "7821", "@count": "3", "@label": "TLR-7 agonist"}, {"@id": "511", "@count": "3", "@label": "TNF antagonist"}, {"@id": "406", "@count": "2", "@label": "Oxidoreductase inhibitor"}, {"@id": "410", "@count": "2", "@label": "GM-CSF receptor agonist"}, {"@id": "7992", "@count": "2", "@label": "Heat shock protein modulator"}, {"@id": "5552", "@count": "2", "@label": "Helicase inhibitor"}, {"@id": "172", "@count": "2", "@label": "Unspecified GPCR agonist"}, {"@id": "1053", "@count": "2", "@label": "Unspecified enzyme inhibitor"}, {"@id": "12789", "@count": "2", "@label": "Anthrax protective antigen modulator"}, {"@id": "2419", "@count": "2", "@label": "p38 MAP kinase inhibitor"}, {"@id": "17119", "@count": "2", "@label": "p53 tumor suppressor protein modulator"}, {"@id": "3265", "@count": "2", "@label": "GHRH receptor agonist"}, {"@id": "2506", "@count": "2", "@label": "PARP modulator"}, {"@id": "62226", "@count": "2", "@label": "GAG gene modulator"}, {"@id": "66340", "@count": "2", "@label": "Penicillin binding protein inhibitor"}, {"@id": "299", "@count": "2", "@label": "Platelet activating factor receptor antagonist"}, {"@id": "71641", "@count": "2", "@label": "Polymerase acidic protein inhibitor"}, {"@id": "12770", "@count": "2", "@label": "B-lymphocyte stimulator ligand inhibitor"}, {"@id": "318", "@count": "2", "@label": "Prostanoid receptor antagonist"}, {"@id": "86", "@count": "2", "@label": "Beta lactamase inhibitor"}, {"@id": "3756", "@count": "2", "@label": "Erbb2 tyrosine kinase receptor inhibitor"}, {"@id": "52110", "@count": "2", "@label": "Respiratory syncytial virus protein F inhibitor"}, {"@id": "3566", "@count": "2", "@label": "Jak3 tyrosine kinase inhibitor"}, {"@id": "20443", "@count": "2", "@label": "Interleukin-28B ligand"}, {"@id": "513", "@count": "2", "@label": "Kallikrein inhibitor"}, {"@id": "12479", "@count": "2", "@label": "Interleukin-1 beta ligand inhibitor"}, {"@id": "18759", "@count": "2", "@label": "Interferon regulatory factor 3 stimulator"}]}, {"@total": "17", "@label": "Drug Deal Types", "@name": "drugDealTypes", "FilterOption": [{"@id": "4", "@count": "388", "@label": "Drug - Development/Commercialization License"}, {"@id": "13", "@count": "330", "@label": "Drug - Funding"}, {"@id": "5", "@count": "192", "@label": "Drug - Commercialization License"}, {"@id": "6", "@count": "159", "@label": "Drug - Manufacturing/Supply"}, {"@id": "3", "@count": "147", "@label": "Drug - Early Research/Development"}, {"@id": "7", "@count": "139", "@label": "Drug - Development Services"}, {"@id": "10", "@count": "107", "@label": "Technology - Other Proprietary"}, {"@id": "8", "@count": "104", "@label": "Technology - Delivery/Formulation"}, {"@id": "11", "@count": "51", "@label": "Patent - Exclusive Rights"}, {"@id": "14", "@count": "42", "@label": "Drug - Asset Divestment"}, {"@id": "2", "@count": "40", "@label": "Drug - Screening/Evaluation"}, {"@id": "15", "@count": "38", "@label": "Drug - CRADA"}, {"@id": "12", "@count": "22", "@label": "Patent - Non-Exclusive Rights"}, {"@id": "1", "@count": "16", "@label": "Drug - Discovery/Design"}, {"@id": "9", "@count": "4", "@label": "Technology - Target Validation"}, {"@id": "16", "@count": "2", "@label": "Technology - Asset Divestment"}, {"@id": "17", "@count": "1", "@label": "Patent - Asset Divestment"}]}, {"@total": "100", "@label": "Secondary Companies", "@name": "companiesSecondary", "FilterOption": [{"@id": "19658", "@count": "27", "@label": "Sankyo Co Ltd"}, {"@id": "28355", "@count": "24", "@label": "GlaxoSmithKline plc"}, {"@id": "18077", "@count": "20", "@label": "Merck & Co Inc"}, {"@id": "15385", "@count": "19", "@label": "Chiron Corp"}, {"@id": "23137", "@count": "15", "@label": "Novartis AG"}, {"@id": "22127", "@count": "14", "@label": "Sanofi Pasteur"}, {"@id": "17810", "@count": "13", "@label": "Eli Lilly & Co"}, {"@id": "19962", "@count": "12", "@label": "SmithKline Beecham plc"}, {"@id": "30578", "@count": "12", "@label": "VGX Pharmaceuticals LLC"}, {"@id": "17006", "@count": "12", "@label": "Idera Pharmaceuticals Inc"}, {"@id": "15065", "@count": "12", "@label": "Bristol-Myers Squibb Co"}, {"@id": "19898", "@count": "10", "@label": "Shionogi & Co Ltd"}, {"@id": "18767", "@count": "10", "@label": "Pfizer Inc"}, {"@id": "13601", "@count": "10", "@label": "Abbott Laboratories"}, {"@id": "1006648", "@count": "9", "@label": "NanoBio Corp"}, {"@id": "16453", "@count": "9", "@label": "Glaxo Group Ltd"}, {"@id": "20520", "@count": "9", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "18751", "@count": "9", "@label": "Acambis plc"}, {"@id": "14240", "@count": "9", "@label": "Sarepta Therapeutics Inc"}, {"@id": "15593", "@count": "8", "@label": "Daiichi Seiyaku Co Ltd"}, {"@id": "14112", "@count": "8", "@label": "Wyeth"}, {"@id": "20743", "@count": "8", "@label": "Vical Inc"}, {"@id": "1033672", "@count": "8", "@label": "TechnoVax Inc"}, {"@id": "14455", "@count": "8", "@label": "Bayer AG"}, {"@id": "18008", "@count": "8", "@label": "MedImmune LLC"}, {"@id": "21210", "@count": "7", "@label": "Medimmune Vaccines Inc"}, {"@id": "14881", "@count": "7", "@label": "Boehringer Ingelheim Corp"}, {"@id": "19711", "@count": "7", "@label": "Schering-Plough Corp"}, {"@id": "16450", "@count": "7", "@label": "Gilead Sciences Inc"}, {"@id": "28463", "@count": "7", "@label": "Intercell AG"}, {"@id": "15336", "@count": "7", "@label": "UCB Celltech"}, {"@id": "15873", "@count": "7", "@label": "Elan Corp plc"}, {"@id": "25813", "@count": "7", "@label": "Vaxin Inc"}, {"@id": "19446", "@count": "7", "@label": "Roche Holding AG"}, {"@id": "14695", "@count": "7", "@label": "BioCryst Pharmaceuticals Inc"}, {"@id": "25218", "@count": "6", "@label": "Aventis Pharma AG"}, {"@id": "23895", "@count": "6", "@label": "Novavax Inc"}, {"@id": "1005416", "@count": "6", "@label": "AVIR Green Hills Biotechnology AG"}, {"@id": "24800", "@count": "6", "@label": "PowderJect Pharmaceuticals plc"}, {"@id": "20524", "@count": "6", "@label": "University of Alabama at Birmingham"}, {"@id": "20199", "@count": "6", "@label": "Solvay SA"}, {"@id": "20596", "@count": "6", "@label": "Johns Hopkins University"}, {"@id": "1017506", "@count": "6", "@label": "Daiichi Sankyo Co Ltd"}, {"@id": "30650", "@count": "6", "@label": "Juvaris BioTherapeutics Inc"}, {"@id": "22006", "@count": "6", "@label": "Pharmacia & Upjohn Inc"}, {"@id": "17084", "@count": "6", "@label": "ID Biomedical Corp"}, {"@id": "16227", "@count": "5", "@label": "Fujisawa Pharmaceutical Co Ltd"}, {"@id": "1002892", "@count": "5", "@label": "VBI Vaccines"}, {"@id": "29945", "@count": "5", "@label": "Pevion Biotech Ltd"}, {"@id": "27120", "@count": "5", "@label": "ANI Pharmaceuticals Inc"}, {"@id": "25584", "@count": "5", "@label": "Pfizer Vaccines"}, {"@id": "21717", "@count": "5", "@label": "Actavis Inc"}, {"@id": "20518", "@count": "5", "@label": "National Institutes of Health"}, {"@id": "17254", "@count": "5", "@label": "Crucell NV"}, {"@id": "24166", "@count": "5", "@label": "GlaxoSmithKline Biologicals"}, {"@id": "19687", "@count": "5", "@label": "Bayer Schering Pharma AG"}, {"@id": "27638", "@count": "5", "@label": "Pharmacia Corp"}, {"@id": "29554", "@count": "4", "@label": "Bionor Pharma ASA"}, {"@id": "15414", "@count": "4", "@label": "Chugai Pharmaceutical Co Ltd"}, {"@id": "17332", "@count": "4", "@label": "Johnson & Johnson"}, {"@id": "27711", "@count": "4", "@label": "CytoGenix Inc"}, {"@id": "1005244", "@count": "4", "@label": "Biogen Idec Inc"}, {"@id": "20300", "@count": "4", "@label": "Takeda Pharmaceutical Co Ltd"}, {"@id": "24236", "@count": "4", "@label": "Cambridge Antibody Technology Group plc"}, {"@id": "15563", "@count": "4", "@label": "CSL Ltd"}, {"@id": "15303", "@count": "4", "@label": "Cantab Biopharmaceuticals Ltd"}, {"@id": "1022888", "@count": "4", "@label": "Vaxart Inc"}, {"@id": "15573", "@count": "4", "@label": "Epimmune Inc"}, {"@id": "1020606", "@count": "4", "@label": "Novartis Vaccines & Diagnostics"}, {"@id": "1008243", "@count": "4", "@label": "PowderMed Ltd"}, {"@id": "14333", "@count": "4", "@label": "TOLMAR Therapeutics Inc"}, {"@id": "27262", "@count": "4", "@label": "Mast Therapeutics Inc"}, {"@id": "20787", "@count": "4", "@label": "Warner-Lambert Co"}, {"@id": "20983", "@count": "4", "@label": "Mitsubishi Pharma Corp"}, {"@id": "26494", "@count": "4", "@label": "Sanofi-Synthelabo"}, {"@id": "1034134", "@count": "4", "@label": "Alios BioPharma Inc"}, {"@id": "24133", "@count": "4", "@label": "Xenova Group plc"}, {"@id": "19453", "@count": "4", "@label": "Genentech Inc"}, {"@id": "1060962", "@count": "4", "@label": "Visterra Inc"}, {"@id": "1050276", "@count": "4", "@label": "AnC Bio Group"}, {"@id": "1015687", "@count": "4", "@label": "IDM Pharma Inc"}, {"@id": "1032384", "@count": "4", "@label": "NasVax Ltd"}, {"@id": "24727", "@count": "4", "@label": "Rega Institute for Medical Research"}, {"@id": "24282", "@count": "3", "@label": "Albert Einstein College of Medicine"}, {"@id": "28431", "@count": "3", "@label": "UMeWorld Limited"}, {"@id": "29636", "@count": "3", "@label": "Isconova AB"}, {"@id": "22413", "@count": "3", "@label": "Biovail Corp"}, {"@id": "14957", "@count": "3", "@label": "ZymeTx Inc"}, {"@id": "1021778", "@count": "3", "@label": "Intrexon Corp"}, {"@id": "28108", "@count": "3", "@label": "4SC AG"}, {"@id": "14042", "@count": "3", "@label": "Allergan Inc"}, {"@id": "14834", "@count": "3", "@label": "Biota Holdings Ltd"}, {"@id": "24437", "@count": "3", "@label": "Ciba-Geigy AG"}, {"@id": "1009547", "@count": "3", "@label": "Sanofi"}, {"@id": "27987", "@count": "3", "@label": "Intercell USA"}, {"@id": "17747", "@count": "3", "@label": "La Jolla Institute of Allergy & Immunology"}, {"@id": "21332", "@count": "3", "@label": "Laboratorios Farmaceuticos Rovi SA"}, {"@id": "1041266", "@count": "3", "@label": "Microgen State Scientific Industrial Company"}, {"@id": "24652", "@count": "3", "@label": "Shire plc"}, {"@id": "1008260", "@count": "3", "@label": "NexBio Inc"}]}, {"@total": "100", "@label": "Primary Companies", "@name": "companiesPrimary", "FilterOption": [{"@id": "28355", "@count": "42", "@label": "GlaxoSmithKline plc"}, {"@id": "23137", "@count": "26", "@label": "Novartis AG"}, {"@id": "18767", "@count": "24", "@label": "Pfizer Inc"}, {"@id": "1009547", "@count": "21", "@label": "Sanofi"}, {"@id": "18077", "@count": "21", "@label": "Merck & Co Inc"}, {"@id": "1020606", "@count": "19", "@label": "Novartis Vaccines & Diagnostics"}, {"@id": "20300", "@count": "18", "@label": "Takeda Pharmaceutical Co Ltd"}, {"@id": "22127", "@count": "17", "@label": "Sanofi Pasteur"}, {"@id": "1017506", "@count": "16", "@label": "Daiichi Sankyo Co Ltd"}, {"@id": "1005255", "@count": "14", "@label": "Sinovac Biotech Ltd"}, {"@id": "19898", "@count": "14", "@label": "Shionogi & Co Ltd"}, {"@id": "20520", "@count": "14", "@label": "National Institute of Allergy and Infectious Diseases"}, {"@id": "19446", "@count": "13", "@label": "Roche Holding AG"}, {"@id": "22403", "@count": "13", "@label": "Inovio Pharmaceuticals Inc"}, {"@id": "16583", "@count": "11", "@label": "Green Cross Corp"}, {"@id": "13601", "@count": "11", "@label": "Abbott Laboratories"}, {"@id": "15065", "@count": "11", "@label": "Bristol-Myers Squibb Co"}, {"@id": "18008", "@count": "10", "@label": "MedImmune LLC"}, {"@id": "15563", "@count": "10", "@label": "CSL Ltd"}, {"@id": "15872", "@count": "10", "@label": "Eisai Co Ltd"}, {"@id": "1006648", "@count": "9", "@label": "NanoBio Corp"}, {"@id": "DOL1000491", "@count": "9", "@label": "Xenetic Biosciences Inc"}, {"@id": "1014809", "@count": "9", "@label": "NanoViricides Inc"}, {"@id": "1013295", "@count": "9", "@label": "Astellas Pharma Inc"}, {"@id": "14190", "@count": "9", "@label": "AstraZeneca plc"}, {"@id": "1088700", "@count": "8", "@label": "Actavis plc"}, {"@id": "17254", "@count": "8", "@label": "Crucell NV"}, {"@id": "1035060", "@count": "8", "@label": "Mitsubishi Tanabe Pharma Corp"}, {"@id": "1008303", "@count": "8", "@label": "iBio Inc"}, {"@id": "17332", "@count": "8", "@label": "Johnson & Johnson"}, {"@id": "29665", "@count": "8", "@label": "Bharat Biotech International Ltd"}, {"@id": "23895", "@count": "8", "@label": "Novavax Inc"}, {"@id": "23408", "@count": "7", "@label": "Sanofi Pasteur MSD"}, {"@id": "18207", "@count": "7", "@label": "Protein Sciences Corp"}, {"@id": "14437", "@count": "7", "@label": "Baxter International Inc"}, {"@id": "20348", "@count": "7", "@label": "Teva Pharmaceutical Industries Ltd"}, {"@id": "23305", "@count": "7", "@label": "Serum Institute of India Ltd"}, {"@id": "26417", "@count": "7", "@label": "AlphaVax Inc"}, {"@id": "20518", "@count": "7", "@label": "National Institutes of Health"}, {"@id": "1012444", "@count": "7", "@label": "Adimmune Corp"}, {"@id": "26914", "@count": "7", "@label": "SK Chemicals Co Ltd"}, {"@id": "1014618", "@count": "7", "@label": "Medicago Inc"}, {"@id": "14881", "@count": "7", "@label": "Boehringer Ingelheim Corp"}, {"@id": "1043985", "@count": "6", "@label": "VGX International"}, {"@id": "20739", "@count": "6", "@label": "Vertex Pharmaceuticals Inc"}, {"@id": "24306", "@count": "6", "@label": "Antigen Express Inc"}, {"@id": "19453", "@count": "6", "@label": "Genentech Inc"}, {"@id": "19962", "@count": "6", "@label": "SmithKline Beecham plc"}, {"@id": "1022888", "@count": "6", "@label": "Vaxart Inc"}, {"@id": "17810", "@count": "6", "@label": "Eli Lilly & Co"}, {"@id": "14695", "@count": "6", "@label": "BioCryst Pharmaceuticals Inc"}, {"@id": "15414", "@count": "6", "@label": "Chugai Pharmaceutical Co Ltd"}, {"@id": "17101", "@count": "6", "@label": "Il Dong Pharmaceutical Co Ltd"}, {"@id": "1012596", "@count": "6", "@label": "Protein Potential LLC"}, {"@id": "1036675", "@count": "6", "@label": "Sirnaomics Inc"}, {"@id": "1015033", "@count": "6", "@label": "Mucosis BV"}, {"@id": "26816", "@count": "6", "@label": "Cytos Biotechnology Ltd"}, {"@id": "1048460", "@count": "5", "@label": "Kineta Inc"}, {"@id": "1040510", "@count": "5", "@label": "Theraclone Sciences Inc"}, {"@id": "31507", "@count": "5", "@label": "CureVac GmbH"}, {"@id": "15411", "@count": "5", "@label": "JW Pharmaceutical Corp"}, {"@id": "1020743", "@count": "5", "@label": "GP Pharm SA"}, {"@id": "14455", "@count": "5", "@label": "Bayer AG"}, {"@id": "16450", "@count": "5", "@label": "Gilead Sciences Inc"}, {"@id": "1044854", "@count": "5", "@label": "Vivaldi Biosciences Inc"}, {"@id": "20573", "@count": "5", "@label": "Emory University"}, {"@id": "1049660", "@count": "5", "@label": "Hualan Biological Engineering Inc"}, {"@id": "17392", "@count": "5", "@label": "Janssen-Cilag Ltd"}, {"@id": "1034204", "@count": "5", "@label": "Etubics Corp"}, {"@id": "1042877", "@count": "5", "@label": "Omninvest"}, {"@id": "19862", "@count": "5", "@label": "Merck Serono SA"}, {"@id": "1033672", "@count": "5", "@label": "TechnoVax Inc"}, {"@id": "22879", "@count": "5", "@label": "Hemispherx Biopharma Inc"}, {"@id": "1031543", "@count": "5", "@label": "Lakewood-Amedex Inc"}, {"@id": "15385", "@count": "5", "@label": "Chiron Corp"}, {"@id": "20452", "@count": "5", "@label": "UCB SA"}, {"@id": "28620", "@count": "5", "@label": "Mymetics Corp"}, {"@id": "19711", "@count": "4", "@label": "Schering-Plough Corp"}, {"@id": "15587", "@count": "4", "@label": "Daewoong Pharmaceutical Co Ltd"}, {"@id": "14240", "@count": "4", "@label": "Sarepta Therapeutics Inc"}, {"@id": "21851", "@count": "4", "@label": "Polymun Scientific Immunobiologische Forschung GmbH"}, {"@id": "1072430", "@count": "4", "@label": "Changchun Changsheng Life Sciences Limited"}, {"@id": "15339", "@count": "4", "@label": "CEL-SCI Corp"}, {"@id": "25623", "@count": "4", "@label": "University of California Los Angeles"}, {"@id": "1064395", "@count": "4", "@label": "SynBio LLC"}, {"@id": "24019", "@count": "4", "@label": "MSD Japan"}, {"@id": "1072507", "@count": "4", "@label": "AbbVie Inc"}, {"@id": "1061252", "@count": "4", "@label": "Wuhan Institute of Biological Products Co Ltd"}, {"@id": "19658", "@count": "4", "@label": "Sankyo Co Ltd"}, {"@id": "24189", "@count": "4", "@label": "Mundipharma AG"}, {"@id": "30212", "@count": "4", "@label": "BioDiem Ltd"}, {"@id": "1011990", "@count": "4", "@label": "Emergent BioSolutions Inc"}, {"@id": "14987", "@count": "4", "@label": "Boryung Pharm Co Ltd"}, {"@id": "24643", "@count": "4", "@label": "Salix Pharmaceuticals Ltd"}, {"@id": "29554", "@count": "4", "@label": "Bionor Pharma ASA"}, {"@id": "1028220", "@count": "4", "@label": "Intas Pharmaceuticals Ltd"}, {"@id": "24154", "@count": "4", "@label": "Recordati SpA"}, {"@id": "14109", "@count": "4", "@label": "Amgen Inc"}, {"@id": "20743", "@count": "4", "@label": "Vical Inc"}, {"@id": "1061553", "@count": "4", "@label": "ContraFect Corp"}]}, {"@total": "12", "@label": "Highest Phase", "@name": "phaseHighest", "FilterOption": [{"@id": "DR", "@count": "480", "@label": "Discovery"}, {"@id": "NDR", "@count": "468", "@label": "No Development Reported"}, {"@id": "L", "@count": "359", "@label": "Launched"}, {"@id": "DX", "@count": "198", "@label": "Discontinued"}, {"@id": "C2", "@count": "145", "@label": "Phase 2 Clinical"}, {"@id": "C1", "@count": "101", "@label": "Phase 1 Clinical"}, {"@id": "C3", "@count": "60", "@label": "Phase 3 Clinical"}, {"@id": "R", "@count": "30", "@label": "Registered"}, {"@id": "S", "@count": "26", "@label": "Suspended"}, {"@id": "PR", "@count": "23", "@label": "Pre-registration"}, {"@id": "CU", "@count": "12", "@label": "Clinical"}, {"@id": "W", "@count": "8", "@label": "Withdrawn"}]}, {"@total": "5", "@label": "Drug Sales 2010 (USD M)", "@name": "drugSalesYearActual", "FilterOption": [{"@count": "47", "@label": "< 100"}, {"@count": "19", "@label": "\u2265 100 and  250"}, {"@count": "14", "@label": "\u2265 250 and  500"}, {"@count": "22", "@label": "\u2265 500 and  1000"}, {"@count": "30", "@label": "\u2265 1000"}]}, {"@total": "8", "@label": "Drug Deals Count", "@name": "drugDealsCount", "FilterOption": [{"@count": "951", "@label": "= 0"}, {"@count": "407", "@label": "> 1 and \u2264 1"}, {"@count": "203", "@label": "> 2 and \u2264 2"}, {"@count": "111", "@label": "> 3 and \u2264 3"}, {"@count": "72", "@label": "> 4 and \u2264 4"}, {"@count": "49", "@label": "> 5 and \u2264 5"}, {"@count": "96", "@label": "> 6 and \u2264 10"}, {"@count": "21", "@label": "> 11"}]}, {"@total": "100", "@label": "Drug Added by Day", "@name": "drugAddedDateByDay", "FilterOption": [{"@count": "232", "@label": "1996-02-16"}, {"@count": "9", "@label": "2009-12-16"}, {"@count": "9", "@label": "2010-07-16"}, {"@count": "6", "@label": "2009-10-06"}, {"@count": "6", "@label": "2010-01-05"}, {"@count": "6", "@label": "2013-12-04"}, {"@count": "5", "@label": "2011-04-25"}, {"@count": "5", "@label": "2012-08-23"}, {"@count": "5", "@label": "2010-04-07"}, {"@count": "5", "@label": "2012-08-30"}, {"@count": "5", "@label": "2009-12-17"}, {"@count": "5", "@label": "2009-12-09"}, {"@count": "5", "@label": "2014-05-12"}, {"@count": "5", "@label": "2009-05-11"}, {"@count": "5", "@label": "2007-03-30"}, {"@count": "5", "@label": "2002-07-10"}, {"@count": "5", "@label": "1998-03-16"}, {"@count": "4", "@label": "2008-06-19"}, {"@count": "4", "@label": "2009-09-14"}, {"@count": "4", "@label": "2005-09-21"}, {"@count": "4", "@label": "2005-10-10"}, {"@count": "4", "@label": "2012-11-30"}, {"@count": "4", "@label": "2012-11-22"}, {"@count": "4", "@label": "2011-08-04"}, {"@count": "4", "@label": "2010-10-14"}, {"@count": "4", "@label": "2010-09-27"}, {"@count": "4", "@label": "2012-09-21"}, {"@count": "4", "@label": "2006-06-13"}, {"@count": "4", "@label": "2010-08-09"}, {"@count": "4", "@label": "2014-04-09"}, {"@count": "4", "@label": "2012-06-13"}, {"@count": "4", "@label": "2006-11-24"}, {"@count": "4", "@label": "2003-03-25"}, {"@count": "4", "@label": "2002-08-12"}, {"@count": "4", "@label": "2013-07-25"}, {"@count": "4", "@label": "2008-01-02"}, {"@count": "4", "@label": "2012-07-27"}, {"@count": "4", "@label": "2013-09-04"}, {"@count": "3", "@label": "2011-04-21"}, {"@count": "3", "@label": "2005-06-09"}, {"@count": "3", "@label": "2007-09-27"}, {"@count": "3", "@label": "2000-01-20"}, {"@count": "3", "@label": "2010-12-13"}, {"@count": "3", "@label": "2010-02-25"}, {"@count": "3", "@label": "2010-11-12"}, {"@count": "3", "@label": "2013-07-18"}, {"@count": "3", "@label": "2010-10-26"}, {"@count": "3", "@label": "2013-06-20"}, {"@count": "3", "@label": "2006-04-20"}, {"@count": "3", "@label": "2007-01-03"}, {"@count": "3", "@label": "2013-05-10"}, {"@count": "3", "@label": "2013-05-28"}, {"@count": "3", "@label": "2006-10-19"}, {"@count": "3", "@label": "2012-05-30"}, {"@count": "3", "@label": "2012-05-29"}, {"@count": "3", "@label": "2012-07-16"}, {"@count": "3", "@label": "2002-07-03"}, {"@count": "3", "@label": "2012-03-28"}, {"@count": "3", "@label": "2012-07-30"}, {"@count": "3", "@label": "2012-08-01"}, {"@count": "3", "@label": "2003-03-24"}, {"@count": "3", "@label": "2012-08-20"}, {"@count": "3", "@label": "2012-08-24"}, {"@count": "3", "@label": "2012-08-28"}, {"@count": "3", "@label": "2012-08-29"}, {"@count": "3", "@label": "2011-12-02"}, {"@count": "3", "@label": "2012-09-11"}, {"@count": "3", "@label": "2011-10-10"}, {"@count": "3", "@label": "2003-11-17"}, {"@count": "3", "@label": "2012-10-02"}, {"@count": "3", "@label": "2011-08-08"}, {"@count": "3", "@label": "2011-07-29"}, {"@count": "3", "@label": "2011-07-21"}, {"@count": "3", "@label": "2011-07-19"}, {"@count": "3", "@label": "2011-07-05"}, {"@count": "3", "@label": "2011-06-27"}, {"@count": "3", "@label": "2011-05-27"}, {"@count": "3", "@label": "2011-05-26"}, {"@count": "3", "@label": "2014-05-06"}, {"@count": "3", "@label": "2009-06-15"}, {"@count": "3", "@label": "2009-06-16"}, {"@count": "3", "@label": "1997-04-07"}, {"@count": "3", "@label": "2008-12-29"}, {"@count": "3", "@label": "2009-08-27"}, {"@count": "3", "@label": "1996-10-11"}, {"@count": "3", "@label": "2008-08-21"}, {"@count": "3", "@label": "2008-01-22"}, {"@count": "3", "@label": "2009-06-18"}, {"@count": "3", "@label": "2008-08-28"}, {"@count": "3", "@label": "2009-07-07"}, {"@count": "3", "@label": "2009-10-13"}, {"@count": "3", "@label": "2014-01-22"}, {"@count": "3", "@label": "1997-06-04"}, {"@count": "3", "@label": "2009-08-20"}, {"@count": "3", "@label": "2008-02-19"}, {"@count": "3", "@label": "2008-02-20"}, {"@count": "3", "@label": "2013-12-20"}, {"@count": "3", "@label": "2013-08-30"}, {"@count": "3", "@label": "2013-12-17"}, {"@count": "3", "@label": "2009-09-11"}]}, {"@total": "2", "@label": "Drug Has Financials", "@name": "drugHasFinancials", "FilterOption": [{"@count": "1728", "@label": "No"}, {"@count": "182", "@label": "Yes"}]}, {"@total": "5", "@label": "Drug Forecast 2015 (USD M)", "@name": "drugSalesYearEstimate", "FilterOption": [{"@count": "1", "@label": "< 100"}, {"@count": "0", "@label": "\u2265 100 and  250"}, {"@count": "0", "@label": "\u2265 250 and  500"}, {"@count": "0", "@label": "\u2265 500 and  1000"}, {"@count": "0", "@label": "\u2265 1000"}]}]}, "SearchResults": {"Drug": [{"CompanyOriginator": "University of Alabama", "CompaniesSecondary": {"Company": "University of Alabama"}, "@name": "peramivir (intravenous, influenza virus infection), University of Alabama/BioCryst/Shionogi/Green Cross", "ActionsPrimary": {"Action": "Exo-alpha sialidase inhibitor"}, "AddedDate": "2007-02-06T00:00:00Z", "Summary": "...launched an iv formulation of peramivir (S-021812; Rapiacta; PeramiFlu), an <b>influenza</b> neuraminidase inhibitor. The product is indicated for the treatment of <b>influenza</b>...approved the 'emergency use' of iv peramivir in patients hospitalized with H1N1 <b>influenza</b> <b>virus</b> <b>infection</b> [1051628]. By November 2009, two US phase III studies in hospitalized patients...approved the emergency use of iv peramivir in patients hospitalized with H1N1 <b>influenza</b> <b>virus</b> <b>infection</b>. Use of the drug was approved in situations when: the patient was not responding...", "@phaseHighest": "Launched", "CompaniesPrimary": {"Company": ["BioCryst Pharmaceuticals Inc", "Green Cross Corp", "PPD Inc", "Shionogi & Co Ltd"]}, "Technologies": {"Technology": ["Intravenous formulation", "Small molecule therapeutic"]}, "IndicationsPrimary": {"Indication": ["Influenza virus A infection", "Influenza virus B infection", "Influenza virus infection"]}, "@id": "56822", "@lastModificationDate": "2014-08-01T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Universite de Sherbrooke", "CompaniesSecondary": {"Company": ["SOCPRA - Sciences Sant\u00e9 Et Humaines", "Universite de Sherbrooke"]}, "@name": "matriptase inhibitors (influenza virus infection), NEOMED", "ActionsPrimary": {"Action": "Matriptase inhibitor"}, "AddedDate": "2013-02-25T00:00:00Z", "Summary": "...matriptase/type two serine protease (TTSP) inhibitors that diminishes virus propagation, as peptidomimetics for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b> [1385578], [1385792], [1453645], [1481843]. In July 2013, lead optimization was ongoing [1453645]. In September 2013, NEOMED planned...strains, respectively [1395410].In January 2013, preclinical data demonstrated a significant reduction in viral replication of H1N1 <b>influenza</b> including 2009 pandemic virus [1385792].", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "NEOMED Institute"}, "Technologies": {"Technology": ["Peptidomimetic", "Small molecule therapeutic"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "83484", "@lastModificationDate": "2013-09-27T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Novavax Inc", "AddedDate": "2009-07-10T00:00:00Z", "@name": "vaccine (influenza virus infection, VLP vaccine technology), Novavax", "Summary": "...based on its recombinant virus-like-particle (VLP) vaccine technology, for the treatment of seasonal and pandemic <b>influenza</b> <b>virus</b> <b>infection</b> [1024509], [1073607]. In June 2009, the vaccine was in preclinical development [1024509]. In February 2010, Novavax...based on Novavax's recombinant virus-like-particle (VLP) vaccine technology, for the treatment of seasonal and pandemic <b>influenza</b> <b>virus</b> <b>infection</b> [1024509]. In June 2009, the vaccine was still in preclinical development [1024509]. However, in February 2010, the...", "IndicationsSecondary": {"Indication": "Influenza virus infection"}, "@phaseHighest": "Discontinued", "ActionsSecondary": {"Action": ["Antiviral", "Protein subunit vaccine", "Therapeutic vaccine"]}, "Technologies": {"Technology": ["Biological therapeutic", "Nanoparticle formulation", "Parenteral formulation unspecified"]}, "CompaniesSecondary": {"Company": ["Laboratorios Farmaceuticos Rovi SA", "Novavax Inc"]}, "@id": "63935", "@lastModificationDate": "2012-10-12T00:00:00Z"}, {"CompanyOriginator": "Rega Institute for Medical Research", "AddedDate": "2013-05-28T00:00:00Z", "@name": "influenza virus polymerase inhibitors (protide, influenza virus infection), Rega Institute for Medical Research/Welsh School of Pharmacy", "ActionsPrimary": {"Action": "Influenza polymerase basic protein inhibitor"}, "Summary": "Rega Institute for Medical Research and Welsh School of Pharmacy are investigating <b>influenza</b> virus polymerase inhibitors which uses ProTide technology for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b> [1427619], [1419864]. In May 2013, preclinical data were presented [1419864].In May 2013, preclinical data of...on synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs which targeted against <b>influenza</b> virus [1427619].", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": ["Rega Institute for Medical Research", "Welsh School of Pharmacy"]}, "Technologies": {"Technology": ["Nucleotide and derivatives", "Parenteral formulation unspecified", "Prodrug", "Small molecule therapeutic"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "85312", "@lastModificationDate": "2013-08-21T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "University of British Columbia", "AddedDate": "2012-06-20T00:00:00Z", "@name": "next-generation neuraminidase inhibitors (influenza virus infection), CDRD/University of British Columbia", "ActionsPrimary": {"Action": "Exo-alpha sialidase inhibitor"}, "Summary": "...small molecule neuraminidase inhibitors, for the potential oral treatment of <b>influenza</b> <b>virus</b> <b>infection</b> [1302046], [1385654], [1344216]. In June 2012, the program was in preclinical...resistant mutant strains, and efficacy had been demonstrated in a murine model of <b>influenza</b> [1344229]; in April 2013, similar preclinical data were published [1385885...The compunds had shown in vitro activity against tamiflu resistant strains of <b>influenza</b> [1501075].By June 2012, proof-of-principle in vitro studies had demonstrated...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": ["Centre for Drug Research and Development", "Commonwealth Scientific and Industrial Research Organization", "University of Bath", "University of British Columbia"]}, "Technologies": {"Technology": ["Oral formulation", "Small molecule therapeutic"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "78808", "@lastModificationDate": "2014-04-30T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA", "CompaniesSecondary": {"Company": "Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA"}, "@name": "peramivir (sodium chloride trihydrate formulation, influenza virus infection), Guangzhou Nanxin Pharmaceutical", "ActionsPrimary": {"Action": "Exo-alpha sialidase inhibitor"}, "AddedDate": "2013-04-08T00:00:00Z", "Summary": "...Military Sciences), has developed an iv sodium chloride trihydrate formulation of peramivir (Li Wei), an <b>influenza</b> neuraminidase inhibitor, for the treatment of <b>influenza</b> A and B virus infection, including pandemic H7N9 [1400375], [1400377], [1400378], [1400389], [1405759...peramivir was approved in China under the accelerated approval process, due to the medical needs for H7N9 <b>influenza</b> epidemic prevention and control [1400375], [1400377].By April 2013, clinical data had shown that the efficacy...", "@phaseHighest": "Registered", "CompaniesPrimary": {"Company": "Guangzhou Nanxin Pharmaceutical Co Ltd"}, "Technologies": {"Technology": ["Intravenous formulation", "Small molecule therapeutic"]}, "IndicationsPrimary": {"Indication": ["Influenza virus A infection", "Influenza virus B infection"]}, "@id": "84301", "@lastModificationDate": "2013-04-19T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Quantum Pharmaceuticals LLC", "AddedDate": "2013-12-04T00:00:00Z", "@name": "nucleoprotein inhibitors (influenza virus infection), Quantum", "ActionsPrimary": {"Action": "Nucleoprotein inhibitor"}, "Summary": "...2,4-triazole derivatives as nucleoprotein inhibitors, for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b> [1504947], [1504997]. In August 2013, preclinical data were published [1504997]; in...4-triazole derivatives. In vitro, the compounds demonstrated to be effective against <b>influenza</b> A virus strains. At that time, the efficacious compounds were successfully tested in an in vivo <b>influenza</b> challenge study in mice. The most active compound (structure shown) exhibited cell cultures...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "Quantum Pharmaceuticals LLC"}, "Technologies": {"Technology": "Small molecule therapeutic"}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "88867", "@lastModificationDate": "2013-12-04T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Kineta Inc", "AddedDate": "2013-05-30T00:00:00Z", "@name": "IRF3 agonists (influenza virus infection), Kineta", "ActionsPrimary": {"Action": "Interferon regulatory factor 3 stimulator"}, "Summary": "...KIN-101 (structure shown) and its analog, KIN-269, for the potential use in the treatment of <b>influenza</b> <b>virus</b> <b>infection</b>. By May 2013, preclinical studies were ongoing [1419891].The company is also investigating IRF3...presented at the 26th ICAR in San Francisco, CA. In A/WSN/33 focus forming assay, KIN-101 inhibited <b>influenza</b> A infection in a dose-dependent manner and decreased levels of <b>influenza</b> A virus proteins. Of the KIN-101 analogs evaluated, KIN-269 (10 microM) exhibited potent antiviral...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "Kineta Inc"}, "Technologies": {"Technology": "Small molecule therapeutic"}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "85454", "@lastModificationDate": "2013-06-04T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Trudeau Institute", "AddedDate": "2012-07-09T00:00:00Z", "@name": "anti-NP mAbs (influenza virus infection), Trudeau Institute", "Summary": "Trudeau Institute is investigating mAbs tartgeting nucleoprotein (NP), for the potential prevention and treatment of <b>influenza</b> <b>virus</b> <b>infection</b> [1306666], [1303366]. In June 2012, development was ongoing [1303366]; in March 2013, this was still the case [1390514]. In June 2012, the Institute was seeking to outlicense the program through the technology transfer company Health Research [1303366].By...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": ["Health Research Inc", "Trudeau Institute"]}, "Technologies": {"Technology": ["Biological therapeutic", "Immunization passive", "Monoclonal antibody"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "79177", "@lastModificationDate": "2013-03-27T00:00:00Z", "ActionsSecondary": {"Action": ["Antiviral", "Unspecified drug target"]}}, {"CompanyOriginator": "Trellis Bioscience Inc", "AddedDate": "2010-10-12T00:00:00Z", "@name": "human mAbs (influenza virus infection), Trellis Bioscience", "Summary": "Trellis Bioscience is investigating human monoclonal antibodies (mAbs) for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b>. In September 2010, the program was in lead identification [1128336]; in January 2014, this was still the case [1514900]. In September 2010, the company's strategy involved seeking to outlicense its programs [1128336].In December 2011, preclinical data on...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "Trellis Bioscience Inc"}, "Technologies": {"Technology": ["Biological therapeutic", "Monoclonal antibody human", "Parenteral formulation unspecified"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "68541", "@lastModificationDate": "2014-01-13T00:00:00Z", "ActionsSecondary": {"Action": ["Antiviral", "Unspecified drug target"]}}, {"CompanyOriginator": "Cocrystal Discovery Inc", "CompaniesSecondary": {"Company": "Cocrystal Discovery Inc"}, "@name": "broad-spectrum antivirals (oral, influenza virus infection), Biozone/Cocrystal", "AddedDate": "2011-06-27T00:00:00Z", "Summary": "Biozone/Cocrystal, following the merger of Cocrystal Discovery with Biozone Pharmaceuticals, is investigating a program of once daily oral broad-spectrum antivirals, for the potential treatment or prevention of <b>influenza</b> <b>virus</b> <b>infection</b> [1203575], [1222505], [1512763].", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "Biozone/Cocrystal Discovery"}, "Technologies": {"Technology": ["Oral formulation", "Small molecule therapeutic"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "72100", "@lastModificationDate": "2014-01-06T00:00:00Z", "ActionsSecondary": {"Action": ["Unspecified drug target", "Viral replication inhibitor"]}}, {"CompanyOriginator": "Biological Mimetics Inc", "AddedDate": "2011-04-12T00:00:00Z", "@name": "hemagglutinin/neuraminidase modulator (antibody, influenza virus infection), Biological Mimetics", "ActionsPrimary": {"Action": ["Exo-alpha sialidase modulator", "Hemagglutinin modulator"]}, "Summary": "Biological Mimetics is investigating a vaccine containing hemagglutinin/neuraminidase (HA/NA) modulating antibodies for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b> including H3N2 [1182599], [1184248], [1049474]. In April 2011, preclinical studies were underway [1182599]; in March 2014, development was...induced viral-specific antibody production showing strong immunogenicity of the major viral structural proteins in the guinea pig model of <b>influenza</b> infection [1184248].", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "Biological Mimetics Inc"}, "Technologies": {"Technology": "Small molecule therapeutic"}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "70936", "@lastModificationDate": "2014-03-12T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "University of Gothenburg", "AddedDate": "2008-03-31T00:00:00Z", "@name": "CTA1-DD/M2e vaccine (influenza virus infection), Goteborg University", "Summary": "...including CTA1-M2e-DD and CTA1-3M2e-DD, for the potential prevention of pandemic <b>influenza</b> <b>virus</b> <b>infection</b> [890854], [892962].In April 2008, preclinical data on CTA1-3M2e-DD were published...conferred strong protective immunity against a lethal challenge infection with the <b>influenza</b> A virus in mice and greater efficacy than the CTA1-M2e-DD construct [892962...strong protective immunity against a potentially lethal challenge infection with <b>influenza</b> virus in mice. The formulation was found to be highly effective for mucosal immunization...", "IndicationsSecondary": {"Indication": "Influenza virus infection"}, "@phaseHighest": "No Development Reported", "ActionsSecondary": {"Action": "Prophylactic vaccine"}, "Technologies": {"Technology": ["Biological therapeutic", "Protein fusion"]}, "CompaniesSecondary": {"Company": "University of Gothenburg"}, "@id": "59763", "@lastModificationDate": "2013-09-24T00:00:00Z"}, {"CompanyOriginator": "Abera Bioscience AB", "AddedDate": "2013-12-24T00:00:00Z", "@name": "vaccine (influenza virus infection), Abera Bioscience/Erasmus University Medical Center", "Summary": "Abera Bioscience in collaboration with Erasmus University Medical Center is investigating a vaccine, for the potential prevention of <b>influenza</b> <b>virus</b> <b>infection</b>. In December 2013, the drug was listed as being in preclinical development [1510596].", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": ["Abera Bioscience AB", "Erasmus University Medical Center Rotterdam"]}, "Technologies": {"Technology": ["Biological therapeutic", "Parenteral formulation unspecified"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "89317", "@lastModificationDate": "2013-12-24T00:00:00Z", "ActionsSecondary": {"Action": "Prophylactic vaccine"}}, {"CompanyOriginator": "Weizmann Institute of Science", "AddedDate": "2013-08-27T00:00:00Z", "@name": "aptamer (influenza virus infection), Weizmann", "ActionsPrimary": {"Action": "Hemagglutinin modulator"}, "Summary": "Weizmann Institute is investigating an aptamer, an oligonucleotide designed to complement the receptor-binding region of the <b>influenza</b> haemagglutinin, for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b> [1469360]. In September 2004, data were published [1469394]. In August 2013, development was ongoing and at that time, the institute was seeking to outlicense the drug through Yeda [1469360]In September 2004, data published showed that the DNA aptamer was capable of inhibiting the hemagglutinin...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": ["Weizmann Institute of Science", "Yeda Research and Development Co Ltd"]}, "Technologies": {"Technology": ["Biological therapeutic", "Oligonucleotide", "Parenteral formulation unspecified"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "87057", "@lastModificationDate": "2013-08-27T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Biotron Ltd", "AddedDate": "2011-12-13T00:00:00Z", "@name": "Virion project (influenza virus infection), Biotron", "ActionsPrimary": {"Action": "Unspecified ion channel inhibitor"}, "Summary": "...small-molecule inhibitors of viroporins (viral proteins with ion channel activity) for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b> [758609], [1247324]. By March 2006, Biotron announced that a number of its compounds had been tested against strains of <b>influenza</b>; one compound showed good activity against the H5N1 strain [758609]. In October 2011, the program was still being investigated for <b>influenza</b> [1229106]. By December 2012, development had been ongoing [1459167]. As part of the Virion program...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "Biotron Ltd"}, "Technologies": {"Technology": "Small molecule therapeutic"}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "74962", "@lastModificationDate": "2013-07-31T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "Crucell Holland BV", "AddedDate": "2013-10-03T00:00:00Z", "@name": "mRNA based vaccine (influenza virus infection), Crucell / CureVac", "Summary": "Crucell and CureVac are investigating an mRNA-based <b>influenza</b> vaccine, using CureVac's RNActive technology based on its antigen sequences, for the potential prevention of <b>influenza</b> <b>virus</b> <b>infection</b> [1483687]. In March 2014, preclinical data were presented [1533004].In March 2014, data were...vaccine. Single administration of RNActive vaccine coding for hemagglutinin and neuraminidase of <b>influenza</b> in PR8-infected mice protected against disease symptoms after lethal challenge. In pigs, the...", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": ["Crucell Holland BV", "CureVac GmbH"]}, "Technologies": {"Technology": ["Biological therapeutic", "Parenteral formulation unspecified", "RNA technology"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "87820", "@lastModificationDate": "2014-04-09T00:00:00Z", "ActionsSecondary": {"Action": ["Adjuvant", "Prophylactic vaccine", "RNA vaccine"]}}, {"CompanyOriginator": "National Institutes of Health", "AddedDate": "2013-07-25T00:00:00Z", "@name": "immunogenic peptides (avian influenza virus infection), NIH/NIH OTT", "Summary": "National Institutes of Health is investigating immunogenic peptides, including neutralizing antibodies, and polypeptides, for the potential prevention or treatment of avian <b>influenza</b> <b>virus</b> <b>infection</b>. In February 2012, vaccine potential of specific peptides and polypeptides was being investigated. At that time, the NIH was seeking to outlicense rights to the program through the National Institutes of Health Office of Technology Transfer [1449219], [1395222], [1456596].", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": "National Institutes of Health"}, "Technologies": {"Technology": ["Biological therapeutic", "Parenteral formulation unspecified", "Peptide"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "86148", "@lastModificationDate": "2013-07-25T00:00:00Z", "ActionsSecondary": {"Action": ["Antiviral", "Unspecified drug target"]}}, {"CompanyOriginator": "Marinomed Biotechnologie GmbH", "AddedDate": "2012-11-30T00:00:00Z", "@name": "Carragelose + neuraminidase inhibitor (influenza virus infection), Marinomed", "ActionsPrimary": {"Action": "Exo-alpha sialidase inhibitor"}, "Summary": "Marinomed is investigating a combination of Carragelose with a neuraminidase inhibitor, as intranasal spray formulation, developed using MAVIREX platform technology, for the potential treatment of <b>influenza</b> <b>virus</b> <b>infection</b>. In November 2012, the combination was in phase II development [1345255], [1345259]; in November 2013, this was still the case [1504803]. In November 2012, the company was seeking to outlicense the product [1345255], [1345259]; in November 2013, this was still the case [1504803].", "@phaseHighest": "Phase 2 Clinical", "CompaniesPrimary": {"Company": "Marinomed Biotechnologie GmbH"}, "Technologies": {"Technology": ["Drug combination", "Nasal formulation", "Natural product", "Oligosaccharide", "Small molecule therapeutic", "Systemic formulation unspecified"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "82116", "@lastModificationDate": "2013-12-04T00:00:00Z", "ActionsSecondary": {"Action": "Antiviral"}}, {"CompanyOriginator": "National Institute of Allergy and Infectious Diseases", "AddedDate": "2007-09-26T00:00:00Z", "@name": "adenovector based vaccine (influenza virus infection), GenVec/NIAID", "Summary": "GenVec and the NIAID's Vaccine Research Center (VRC) are investigating an adenovector-based vaccine for the potential treatment of pandemic and seasonal <b>influenza</b> <b>virus</b> <b>infection</b> [649632]. In March 2010, preclinical development was ongoing [1083831], [1078883]; in December 2011, development was ongoing [1248119]. The vaccine was developed using the company\u2019s 293-ORF6 production cell line and its proprietary adenovector technology [649632].", "@phaseHighest": "Discovery", "CompaniesPrimary": {"Company": ["GenVec Inc", "National Institute of Allergy and Infectious Diseases"]}, "Technologies": {"Technology": ["Biological therapeutic", "Virus recombinant"]}, "IndicationsPrimary": {"Indication": "Influenza virus infection"}, "@id": "58234", "@lastModificationDate": "2013-02-04T00:00:00Z", "ActionsSecondary": {"Action": ["Antiviral", "Recombinant viral vector vaccine", "Therapeutic vaccine"]}}]}, "@hits": "20", "@totalResults": "1910", "@offset": "0"}}